Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1. (Q42610797)

From Wikidata

Jump to navigation Jump to search

scientific article published on 23 July 2011

Language	Label	Description	Also known as
English	Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1.	scientific article published on 23 July 2011

Statements

scholarly article

1 reference

Europe PubMed Central

3 November 2017

Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1. (English)

1 reference

Europe PubMed Central

3 November 2017

0 references

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

3 November 2017

author name string

Jean-Pierre Routy

2

1 reference

Europe PubMed Central

3 November 2017

language of work or name

0 references

publication date

23 July 2011

1 reference

Europe PubMed Central

3 November 2017

1 reference

Europe PubMed Central

3 November 2017

29

1 reference

Europe PubMed Central

3 November 2017

38

1 reference

Europe PubMed Central

3 November 2017

6454-6463

1 reference

Europe PubMed Central

3 November 2017

Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

The challenge of viral reservoirs in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Immunopathogenesis and immunotherapy in AIDS virus infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Lack of T-cell proliferative response to HIV-1 antigens after 1 year of highly active antiretroviral treatment in early HIV-1 disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

The role of CD4+ T cell help and CD40 ligand in the in vitro expansion of HIV-1-specific memory cytotoxic CD8+ T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Progress in defining CD4 helper cell responses in chronic viral infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Immunology. CD8 T cells remember with a little help

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Similarities and differences in CD4+ and CD8+ effector and memory T cell generation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Impacts of Avidity and Specificity on the Antiviral Efficiency of HIV-1-Specific CTL

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Exploiting dendritic cells to improve vaccine efficacy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Decreased stimulation of CD4+ T cell proliferation and IL-2 production by highly enriched populations of HIV-infected dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Therapeutic vaccines against HIV need international partnerships

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Immunobiology of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Induction of protective immune responses against R5 human immunodeficiency virus type 1 (HIV-1) infection in hu-PBL-SCID mice by intrasplenic immunization with HIV-1-pulsed dendritic cells: possible involvement of a novel factor of human CD4(+) T-ce

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Generation of specific Th1 and CD8+ T-cell responses by immunization with mouse CD8+ dendritic cells loaded with HIV-1 viral lysate or envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Therapeutic dendritic-cell vaccine for simian AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

A pilot clinical trial of HIV antigen-pulsed allogeneic and autologous dendritic cell therapy in HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Therapeutic dendritic-cell vaccine for chronic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Therapeutic Immunization with Dendritic Cells Loaded with Heat‐Inactivated Autologous HIV‐1 in Patients with Chronic HIV‐1 Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Peptide-loaded dendritic-cell vaccination followed by treatment interruption for chronic HIV-1 infection: a phase 1 trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

A therapeutic dendritic cell-based vaccine for HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Dendritic cell-based human immunodeficiency virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Dendritic cell immunotherapy for HIV infection: from theory to reality

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Role of dendritic cells in HIV-immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Production of a dendritic cell-based vaccine containing inactivated autologous virus for therapy of patients with chronic human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

In vitro human immunodeficiency virus eradication by autologous CD8(+) T cells expanded with inactivated-virus-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Priming of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cell responses by dendritic cells loaded with HIV-1 proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Levels of antigen processing machinery components in dendritic cells generated for vaccination of HIV-1+ subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Primary human immunodeficiency virus type 1-specific CD8+ T-cell responses induced by myeloid dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Processing and presentation of exogenous HLA class I peptides by dendritic cells from human immunodeficiency virus type 1-infected persons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Efficient in vitro expansion of human immunodeficiency virus (HIV)-specific T-cell responses by gag mRNA-electroporated dendritic cells from treated and untreated HIV type 1-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

HIV gag mRNA transfection of dendritic cells (DC) delivers encoded antigen to MHC class I and II molecules, causes DC maturation, and induces a potent human in vitro primary immune response.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Functional T-cell responses generated by dendritic cells expressing the early HIV-1 proteins Tat, Rev and Nef.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Selective induction of host genes by MVA-B, a candidate vaccine against HIV/AIDS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Distinct gene expression profiling after infection of immature human monocyte-derived dendritic cells by the attenuated poxvirus vectors MVA and NYVAC.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Mature dendritic cells infected with canarypox virus elicit strong anti-human immunodeficiency virus CD8+ and CD4+ T-cell responses from chronically infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Dendritic cells exposed to MVA-based HIV-1 vaccine induce highly functional HIV-1-specific CD8(+) T cell responses in HIV-1-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Phenotype and functional analysis of human monocytes-derived dendritic cells loaded with a carbosilane dendrimer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Dendritic cells loaded with HIV-1 p24 proteins adsorbed on surfactant-free anionic PLA nanoparticles induce enhanced cellular immune responses against HIV-1 after vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Dendritic cell-based vaccine strategy against human immunodeficiency virus clade C: skewing the immune response toward a helper T cell type 2 profile

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Immune hierarchy among HIV-1 CD8+ T cell epitopes delivered by dendritic cells depends on MHC-I binding irrespective of mode of loading and immunization in HLA-A*0201 mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Phenotypic and functional characteristics of HIV-specific CD8 T cells and gag sequence variability after autologous dendritic cells based therapeutic vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Regulatory T cell suppression of Gag-specific CD8 T cell polyfunctional response after therapeutic vaccination of HIV-1-infected patients on ART.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Assessment of migration of HIV-1-loaded dendritic cells labeled with 111In-oxine used as a therapeutic vaccine in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Presentation of exogenous whole inactivated simian immunodeficiency virus by mature dendritic cells induces CD4+ and CD8+ T-cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Activation of HIV-1 specific CD4 and CD8 T cells by human dendritic cells: roles for cross-presentation and non-infectious HIV-1 virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.043

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2011.07.043

1 reference

Europe PubMed Central

3 November 2017

1 reference

Europe PubMed Central

3 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42610797&oldid=1790182892"